Pharmaceutical, Healthcare & Medical Devices Webinar Library
Upcoming Webinars
- Screening of Impurities for Mutagenic Potential: How to Perform an ICH M7-Compliant Assessment
26 October 2023 | 11am EDT, 3pm GMT, 5pm CEST
REGISTER
On Demand Webinars
Regulatory Support
- US and Canadian Regulatory Landscape for Rare Disease Drug Development - Recorded July 13, 2021
- Considerations for Deriving Health-Based Exposure Limits for Active Pharmaceutical Ingredients - Recorded June 21, 2018
- Prérequis pour déterminer les valeurs limites d’exposition de principes actifs pharmaceutiques - Recorded June 19, 2018
- Comparison of Health Claim Frameworks Between the U.S., EU, and Other Jurisdictions - Recorded Nov 23, 2015
Toxicology Support
- Méthodes in silico pour l'évaluation toxicologique - Recorded June 6, 2023
- In Silico Methods for Toxicological Assessment - Recorded May 24, 2023
- Safety Assessment of Pharmaceuticals Impurities (ICH Q3A, ICH Q3B and ICH M7) - Recorded May 16, 2023
- Évaluation de la sécurité des impuretés pharmaceutiques (ICH Q3A, ICH Q3B et ICH M7) - Recorded April 15, 2023
- Determination of Health Based Exposure Limit of chemicals substances: Permitted Daily Exposure and Occupational Exposure Limit - Recorded June 23, 2022
- Drug Product Impurities: Analytical and Toxicological Considerations - Recorded November 5, 2020
- Best Practices For E&L Studies: From Chemical Analysis to Tox Assessment - Recorded October 29, 2020